China

India has witnessed a dramatic surge in oilmeal exports to China, increasing twenty-fold in recent months, according to the Solvent Extractors’ Association of India (SEA). Driven by robust Chinese demand for soybean meal, rapeseed meal, and other protein-rich feed components, Indian exporters have capitalized on favorable trade conditions, pricing, and supply reliability. 

Zydus Lifesciences has received regulatory approval in China for its innovative drug Desidustat, a treatment designed to address renal anemia in patients suffering from chronic kidney disease (CKD). The approval from China’s National Medical Products Administration (NMPA) represents a significant milestone for the Indian pharmaceutical company as it expands its presence in one of the world’s largest healthcare markets. The drug will be commercialized through an exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd.